NASDAQ: NRC - National Research Corporation

Rentabilität für sechs Monate: -33.17%
Dividendenrendite: +2.06%
Sektor: Healthcare

Aktionsplan National Research Corporation


Über das Unternehmen National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

weitere details
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

IPO date 1997-10-10
ISIN US6373722023
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.72
Дивиденд ао 0.48
Сайт https://www.nrchealth.com
Цена ао 14.59
Preisänderung pro Tag: +1.64% (14.59)
Preisänderung pro Woche: -1.85% (15.11)
Preisänderung pro Monat: -14.03% (17.25)
Preisänderung über 3 Monate: -16.64% (17.79)
Preisänderung über sechs Monate: -33.17% (22.19)
Preisänderung pro Jahr: -62.38% (39.42)
Preisänderung über 3 Jahre: -60.76% (37.79)
Preisänderung über 5 Jahre: -78.48% (68.92)
Preisänderung über 10 Jahre: 0% (14.83)
Preisänderung seit Jahresbeginn: -16.87% (17.84)

Unterschätzung

Name Bedeutung Grad
P/S 6.63 1
P/BV 20.11 1
P/E 31.79 5
EV/EBITDA 22.12 5
Gesamt: 4.13

Effizienz

Name Bedeutung Grad
ROA, % 25.3 8
ROE, % 63.26 10
Gesamt: 7.33

Dividenden

Name Bedeutung Grad
Div yield, % 2.06 5.15
DSI 0.8571 8.57
Gesamt: 5.64

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.8109 9
Gesamt: 8.4

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 16.08 3
Rentabilität Ebitda, % -4.4 0
Rentabilität EPS, % -0.3763 0
Gesamt: 0.6

Dividende, % Dividende Basierend auf den Ergebnissen des Zeitraums Vorher kaufen Anmeldeschlussdatum Auszahlung vorher
3.26% 0.476 III кв. 2024 25.12.2024 27.12.2024 13.01.2025
0.39% 0.12 II кв. 2024 25.09.2024 27.09.2024 14.10.2024
0.3% 0.12 IV кв. 2023 25.03.2024 27.03.2024 11.04.2024
0.29% 0.12 III кв. 2023 26.12.2023 28.12.2023 12.01.2024

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.06502 18.2 1.66828
iShares Russell 2000 Growth ETF 0.02498 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.01365 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01365 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.00669 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00669 391.25 1.60498
iShares Russell 3000 ETF 0.00055 24.83 1.43482
SPDR Portfolio Europe ETF 0.00011 8.94 3.66537
Dimensional International Core Equity 2 ETF 0.00006 6.52 3.69996



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (70 Jahre)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (60 Jahre)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (52 Jahr)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (49 Jahre)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (53 Jahr)
Ms. Linda Stacy Secretary N/A
Ms. Vinitha Ramnathan Chief Product Officer

Adresse: United States, Lincoln. NE, 1245 Q Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.nrchealth.com